WA
LFCR icon

WFG Advisors’s Lifecore Biomedical LFCR Stock Holding History

WFG Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9
Closed – – 1938
2014
Q4 		$0 Buy
+9
New +$116 ﹤0.01% 2171
2014
Q1 		– Sell
-139
Closed -$2K – 2120
2013
Q4 		$2K Buy
139
+22
+19% +$263 ﹤0.01% 1972
2013
Q3 		$1K Buy
117
+53
+83% +$740 ﹤0.01% 2045
2013
Q2 		$1K Buy
+64
New +$885 ﹤0.01% 1962

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WFG Advisors's LFCR Position: Q1 2015 in Review

WFG Advisors sold out of Lifecore Biomedical (LFCR) in Q1 2015, closing a stake of 9 shares.

WFG Advisors first reported a position in LFCR in Q2 2013 and held it in 4 quarters. The position peaked at $2K in Q4 2013. 99 funds tracked by Wall St. Rank hold LFCR as of Q1 2015.

  • WFG Advisors reported no remaining Lifecore Biomedical position as of Q1 2015 after selling out during the quarter.
  • WFG Advisors sold 9 Lifecore Biomedical shares in Q1 2015.
  • WFG Advisors first reported a position in Lifecore Biomedical in Q2 2013 and held it in 4 quarters.
  • WFG Advisors's Lifecore Biomedical position peaked at $2K in Q4 2013.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2015.

Based on WFG Advisors's 13F filing for Q1 2015, filed 12 May 2015.